These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 11164111
1. Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood. Condiotti R, Zakai YB, Barak V, Nagler A. Exp Hematol; 2001 Jan; 29(1):104-13. PubMed ID: 11164111 [Abstract] [Full Text] [Related]
2. Umbilical cord mesenchymal stem cells increase expansion of cord blood natural killer cells. Boissel L, Tuncer HH, Betancur M, Wolfberg A, Klingemann H. Biol Blood Marrow Transplant; 2008 Sep; 14(9):1031-1038. PubMed ID: 18721766 [Abstract] [Full Text] [Related]
3. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells. Klöß S, Oberschmidt O, Morgan M, Dahlke J, Arseniev L, Huppert V, Granzin M, Gardlowski T, Matthies N, Soltenborn S, Schambach A, Koehl U. Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809 [Abstract] [Full Text] [Related]
4. Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice. Hoyle C, Bangs CD, Chang P, Kamel O, Mehta B, Negrin RS. Blood; 1998 Nov 01; 92(9):3318-27. PubMed ID: 9787169 [Abstract] [Full Text] [Related]
5. Ex vivo expansion of T, NK and CD34+ cells from umbilical cord blood. Wei YM, Cao Q, Zhou HY, Xia R, Lan JC, Meng FY, Bai H. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec 01; 13(6):1076-81. PubMed ID: 16403284 [Abstract] [Full Text] [Related]
9. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions. Carayol G, Robin C, Bourhis JH, Bennaceur-Griscelli A, Chouaib S, Coulombel L, Caignard A. Eur J Immunol; 1998 Jun 01; 28(6):1991-2002. PubMed ID: 9645381 [Abstract] [Full Text] [Related]
10. A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells. Carlens S, Gilljam M, Chambers BJ, Aschan J, Guven H, Ljunggren HG, Christensson B, Dilber MS. Hum Immunol; 2001 Oct 01; 62(10):1092-8. PubMed ID: 11600215 [Abstract] [Full Text] [Related]
12. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells. Gaddy J, Broxmeyer HE. Cell Immunol; 1997 Sep 15; 180(2):132-42. PubMed ID: 9341743 [Abstract] [Full Text] [Related]
13. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. Dunne J, Lynch S, O'Farrelly C, Todryk S, Hegarty JE, Feighery C, Doherty DG. J Immunol; 2001 Sep 15; 167(6):3129-38. PubMed ID: 11544298 [Abstract] [Full Text] [Related]
14. Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity. Shah N, Martin-Antonio B, Yang H, Ku S, Lee DA, Cooper LJ, Decker WK, Li S, Robinson SN, Sekine T, Parmar S, Gribben J, Wang M, Rezvani K, Yvon E, Najjar A, Burks J, Kaur I, Champlin RE, Bollard CM, Shpall EJ. PLoS One; 2013 Sep 15; 8(10):e76781. PubMed ID: 24204673 [Abstract] [Full Text] [Related]
15. Generation of functional natural killer and dendritic cells in a human stromal-based serum-free culture system designed for cord blood expansion. Frias AM, Porada CD, Crapnell KB, Cabral JM, Zanjani ED, Almeida-Porada G. Exp Hematol; 2008 Jan 15; 36(1):61-8. PubMed ID: 18155552 [Abstract] [Full Text] [Related]
16. Expansion of CD56+ NK T and gamma delta T cells from cord blood of human neonates. Musha N, Yoshida Y, Sugahara S, Yamagiwa S, Koya T, Watanabe H, Hatakeyama K, Abo T. Clin Exp Immunol; 1998 Aug 15; 113(2):220-8. PubMed ID: 9717971 [Abstract] [Full Text] [Related]
17. High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy. Spanholtz J, Tordoir M, Eissens D, Preijers F, van der Meer A, Joosten I, Schaap N, de Witte TM, Dolstra H. PLoS One; 2010 Feb 15; 5(2):e9221. PubMed ID: 20169160 [Abstract] [Full Text] [Related]
18. Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission. Torelli GF, Guarini A, Maggio R, Alfieri C, Vitale A, Foà R. Haematologica; 2005 Jun 15; 90(6):785-92. PubMed ID: 15951291 [Abstract] [Full Text] [Related]
19. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering. Ayello J, van de Ven C, Fortino W, Wade-Harris C, Satwani P, Baxi L, Simpson LL, Sanger W, Pickering D, Kurtzberg J, Cairo MS. Biol Blood Marrow Transplant; 2006 Jun 15; 12(6):608-22. PubMed ID: 16737934 [Abstract] [Full Text] [Related]
20. Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12. Bennett IM, Zatsepina O, Zamai L, Azzoni L, Mikheeva T, Perussia B. J Exp Med; 1996 Nov 01; 184(5):1845-56. PubMed ID: 8920872 [Abstract] [Full Text] [Related] Page: [Next] [New Search]